Skip to content

Medical emergency? What to do

Australian firm to start trials of bird flu vaccine

3-RXPublished September 23, 20052 min read

Key points

  • Australian company CSL Ltd will begin human trials of a bird flu vaccine next month as the government warned travelers on Thursday about an outbreak of the deadly virus in parts of Asia.
  • Bird flu has killed a confirmed 64 people in Asia since late 2003.
  • "What we're testing in the trials is the dose that we need to use for the vaccine to be effective.
  • "In an emergency, if the dose that we tested was successful and the strain remains the same, it would take us three months to produce 40 million doses.

Australian company CSL Ltd will begin human trials of a bird flu vaccine next month as the government warned travelers on Thursday about an outbreak of the deadly virus in parts of Asia.

CSL is the world's top maker of human plasma products and spokeswoman Rachel David said the vaccine against the H5N1 strain of avian flu would be tested on 400 human volunteers. Results are expected by the end of the year.

Bird flu has killed a confirmed 64 people in Asia since late 2003. Indonesia is suffering an outbreak of the disease, which has killed at least four people while 11 are under observation in hospital with bird flu-like symptoms.

The Australian government gave CSL A$5 million in July to fast-track development of a vaccine.

"What we're testing in the trials is the dose that we need to use for the vaccine to be effective. The technology is tried and true but what we need to find out with this completely new strain is whether the doses we are using are effective," David said.

She said if the tests were successful then the vaccine could be rushed into production if needed.

"In an emergency, if the dose that we tested was successful and the strain remains the same, it would take us three months to produce 40 million doses. We would start to get the product out of the factory within six weeks," she said.

The most advanced bird flu vaccine is one developed by France's Sanofi-Aventis, which has proved effective at stimulating an immune system response in healthy adults.

"That used an enormous dose of antigen. In fact, the dose of antigen was so large that we wouldn't even go down that path because it would just take too long to make," David said. Antigen is the key vaccine component that triggers an immune response.

"Essentially we are all sharing information so that whoever comes up with the preferred process can share the information as quickly as possible."

U.S.-based Chiron Corp. aims to test its H5N1 vaccine later this year and Britain's GlaxoSmithKline Plc plans large-scale clinical trials in 2006.

The Australian government reissued a flood of travel warnings for Asia to alert Australians to the bird flu outbreak.

The H5N1 strain first emerged in Hong Kong in 1997, where it killed six people, and surfaced again on the Korean peninsula in 2003.

It has since been found in birds in Cambodia, China, Indonesia, Japan, Kazakhstan, Laos, Malaysia, Mongolia, Philippines, Russia, Taiwan, Thailand and Vietnam.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Experimental drug shrinks cancer tumors

An experimental cancer drug successfully shrank tumors in patients with different kinds of cancer, including typically hard-to-treat lung cancers, according to a new study. Oncologists said the research was…

4 min read

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.